Weiss Multi Strategy Advisers LLC Arcutis Biotherapeutics, Inc. Transaction History

Weiss Multi Strategy Advisers LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.84 - $4.82 $176,708 - $462,898	96,037 Added 129.84%	170,000 $549,000
Q3 2023 Nov 14, 2023	SELL	$5.31 - $10.98 $1.04 Million - $2.14 Million	-194,984 Reduced 72.5%	73,963 $393,000
Q2 2023 Aug 14, 2023	BUY	$7.51 - $15.0 $1.06 Million - $2.12 Million	141,011 Added 110.22%	268,947 $2.56 Million
Q1 2023 May 15, 2023	BUY	$10.23 - $17.14 $1.31 Million - $2.19 Million	127,936 New	127,936 $1.41 Million

172

126M

498K

1.64M

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $560M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.